printlogo
http://www.ethz.ch/index_EN
Strategic Excellence Projects: A program promoting innovation through cooperation across disciplines and universities.
 
print
  

SEP Life Sciences and Medical Engineering

Functional Genomics Center Zürich

Functional Genomics Center Zürich
Functional Genomics Center Zürich

Biomedical Engineering

Latest improvements in image acquisition and processing allow acquiring images with higher temporal and spatial resolution in real time
Latest improvements in image acquisition and processing allow acquiring images with higher temporal and spatial resolution in real time. As an example the improvements are shown for the beating heart.
Recent advances in magnetic resonance research have opened up new opportunities to track connection fibers between different brain areas using diffusion tensor imaging (DTI)
Recent advances in magnetic resonance research have opened up new opportunities to track connection fibers between different brain areas using diffusion tensor imaging (DTI).

Overview
Life Science and Medical Engineering are generally considered to be the sciences of the 21st century. Together with the University of Zürich, the Functional Genomics Center Zürich (FGCZ) was established, an infrastructure and center of expertise with a focus on the function and regulation of the (decoded) genes, on proteomics and on bioinformatics (see overview below).

In Medical Engineering this SEP supports large scale research projects in tissue engineering and imaging research. A master's program in biomedical engineering will also emerge from this SEP.

The excellent collaboration between ETH, the University of Zürich, and the Hospital of the University of Zürich (USZ) in this field is one of the strong assets of this SEP (see also biomedical engineering overview below).

----------------------------------------------------------------------------------------

Functional Genomics Center Zürich (FGCZ)
The FGCZ came into existance in February 2002 with the mission to establish technologies and expertise in the field of functional genomics. To date, eight experts in the fields of transcriptomics, proteomics and bioinformatics, supported by an administrative staff, establish technologies and provide training to research scientists in Zürich.

Technological platforms established comprise a high quality facility for the production of custom microarrays, as well as a commercial high-density oligonucleotide GeneChip system. A row of ion-trap mass spectrometers, together with specialized mass spectrometry equipment (Q-TOF), as well as systems for the study of protein interactions, are used in a wide variety of proteomics projects. Together with the FGCZ's infrastructure in robotics and automation, these technologies constantly expand the range of projects which benefit from the technology and expertise provided.

A total of 87 research projects have been started at the Center since the beginning of 2002. From the ongoing projects, several have already reached publication in major scientific journals. Furthermore, the support provided to the local scientific community has been expanded towards teaching and training courses in the practical use of the technologies, as well as to computer-supported data analysis.

The immediate future of the FGCZ will concentrate on the completion of the series of technologies needed to cover the majority of research questions in functional genomics and will also be focused on the establishment of large heterogeneous data collections and the bioinformatical tools needed to exploit them.

Dr. Ralph Schlapbach

----------------------------------------------------------------------------------------

Medical Engineering

Biomedical Engineering (BME) is an interdisciplinary field in which the principles of mathmatics, engineering, and physics are applied to medical and biological research and clinical practice. The work in BME is motivated by the goal of improving human health through the prevention, diagnosis and treatment of human disease. The goal of this SEP is to develop an internationally-recognized integrated Biomedical Engineering Program. The traditionally strong collaboration between ETH, the University of Zurich, and the University Hospital in the field of Biomedical Engineering is one of the most valuable assets of this SEP.

The following programs are currently being supported:

Novel MRI Methods for Diagnosis of Cardiovascular and Neurological Disease

Load Regulated Genes in Trabecular Bone

Also emerging from this SEP will be the creation of a Graduate School in Biomedical Engineering. In the first stage, a master's program in Biomedical Engineering (MS-BME) will be offered with tracks envisaged in the areas of Biocomputing, Bioimaging, Biomechanics, Biomaterials & Tissue Engineering and Bioinstrumentation. This program will provide the needed training for students interested in a career in technology-oriented biological and medical research and industry.

Dr. Marcy Wong

 

Wichtiger Hinweis:
Diese Website wird in älteren Versionen von Netscape ohne graphische Elemente dargestellt. Die Funktionalität der Website ist aber trotzdem gewährleistet. Wenn Sie diese Website regelmässig benutzen, empfehlen wir Ihnen, auf Ihrem Computer einen aktuellen Browser zu installieren. Weitere Informationen finden Sie auf
folgender Seite.

Important Note:
The content in this site is accessible to any browser or Internet device, however, some graphics will display correctly only in the newer versions of Netscape. To get the most out of our site we suggest you upgrade to a newer browser.
More information

© 2012 ETH Zurich | Imprint | Disclaimer | 23 May 2005
top